| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 06/09/2004 | CN1152806C Electronic dispensing system for Chinese medicines |
| 06/09/2004 | CN1152718C Stable oxaliplatin solution preparation and preparation process thereof |
| 06/09/2004 | CN1152717C Oral medicinal preparation |
| 06/09/2004 | CN1152713C Dried blood factor composition comprising trehalose |
| 06/09/2004 | CN1152712C Freeze-dried composition of bone morphogenetic protein human MP52 |
| 06/09/2004 | CN1152709C Phospholipid capsule compsotion with effective blood-lipid regulation function and use thereof |
| 06/09/2004 | CN1152708C Granular medicine for treating stagnancy of qi and blood stasis type cardio-cerebro vascular disease and its preparing process |
| 06/09/2004 | CN1152705C Antalgic moxibustion |
| 06/09/2004 | CN1152689C Activated vitamin D3 emulsion-type lotions |
| 06/09/2004 | CN1152684C Release-regulating preparations |
| 06/09/2004 | CN1152680C Pharmaceutical composition containing liphase inhibitors and chitosan |
| 06/09/2004 | CN1152674C Fluoroether compositions and methods for inhibiting their degradation in the presence of a lewis acid |
| 06/09/2004 | CN1152673C Dermatological patch sheet and process for producing base sheet therefor |
| 06/09/2004 | CN1152672C Method and compositions for enhancing skin permeation of drugs using permeation enhancers |
| 06/09/2004 | CN1152671C Multiple unit pharmaceutical preparation containing proton pump inhibitor |
| 06/09/2004 | CN1152670C Solid delivery systems for controlled release of molecules incorporated therein and methods of making same |
| 06/09/2004 | CN1152669C Medicinal aerosol preparation, its preparing method and release device |
| 06/08/2004 | US6748250 Method and system of monitoring a patient |
| 06/08/2004 | US6747059 Composition for, and methods of, anti-platelet therapy |
| 06/08/2004 | US6747058 Stable composition for inhalation therapy comprising delta-9-tetrahydrocannabinol and semiaqueous solvent therefor |
| 06/08/2004 | US6747019 Mixture of estrogen, progesterone; alternating dosage |
| 06/08/2004 | US6747018 Treatment of estrogen-dependent disorders; preferred compounds have 1,3,5-estratriene nucleus, and are substituted at c-17 or c-11 with molecular moiety which renders compounds effective to block binding of estrogen to its receptor |
| 06/08/2004 | US6747014 For therapy of inflammatory bowel disorder |
| 06/08/2004 | US6746791 Nano-ionic products and devices |
| 06/08/2004 | US6746693 Pharmaceutical excipient having improved compressibility |
| 06/08/2004 | US6746692 Modified release pharmaceutical formulation comprising amoxycillin |
| 06/08/2004 | US6746691 Intermediate release nicotinic acid formulation having a dissolution curve similarity fit factor of about 79, and in in vitro dissolution profile in deionized water at about 100rpm; time release agents; fda orange book listed patent for niacin and simvastatin |
| 06/08/2004 | US6746690 Process for producing composite preparation containing nucleic acid |
| 06/08/2004 | US6746689 Intradermal-penetration agents for topical local anesthetic administration |
| 06/08/2004 | US6746688 Alkyl-ester of levodopa in solvent |
| 06/08/2004 | US6746683 Nontoxic pesticide, and method of using the same |
| 06/08/2004 | US6746677 For preventing and controlling helminthiasis, infection by acarids and arthropod endo-and ectoparasites and bacterial and viral disease in warm-blooded animals |
| 06/08/2004 | US6746667 Adhesive treatment for tinea pedis |
| 06/08/2004 | US6746635 Methods for micronization of hydrophobic drugs |
| 06/08/2004 | US6746529 Moisture and oxygen resistance; high molecular weight film former with mono, di and trisaccharides and maltodextrin |
| 06/08/2004 | US6745764 Apparatus and method for providing a conscious patient relief from pain and anxiety associated with medical or surgical procedures |
| 06/08/2004 | US6745763 Vaporizing device for administering sterile medication |
| 06/08/2004 | CA2201358C Pharmaceutical composition |
| 06/08/2004 | CA2134535C Method for sterilizing recombinant human serum albumin pharmaceutical preparation |
| 06/03/2004 | WO2004046328A2 Bioerodible poly(ortho esters) from dioxane-based di(ketene acetals), and block copolymers containing them |
| 06/03/2004 | WO2004046202A2 Bio-degradable colloid particles, in particular for pulmonary applications |
| 06/03/2004 | WO2004046200A1 Sustained release drug carrier |
| 06/03/2004 | WO2004046165A2 Treatment of ophthalmic conditions with kpv and kpv dimers |
| 06/03/2004 | WO2004046135A1 Stable lansoprazole containing more than 500 ppm, up to about 3,000 ppm water and more than 200 ppm, up to about 5,000 ppm alcohol |
| 06/03/2004 | WO2004045647A1 Amplification of biotin-mediated targeting |
| 06/03/2004 | WO2004045646A1 Pharmaceutical compositions having a modified vehicle |
| 06/03/2004 | WO2004045641A2 Antigen-complexes |
| 06/03/2004 | WO2004045633A2 Pharmaceutical composition comprising octreotide microparticles |
| 06/03/2004 | WO2004045622A1 Pharmaceutical dosage forms of biguanide-sulfonylurea combinations |
| 06/03/2004 | WO2004045621A1 Process to minimize loss through adhesion to equipment surfaces |
| 06/03/2004 | WO2004045619A1 Freeze-dried lecithin nanometer powder injection of ursolic acid and it's preparation method |
| 06/03/2004 | WO2004045608A1 Pharmaceutical compositions containing a biguanide-glitazone combination |
| 06/03/2004 | WO2004045589A1 Modified release composition comprising a short-acting hypnotic for treatment of sleep disorders |
| 06/03/2004 | WO2004045588A1 Palatable micro-capsules |
| 06/03/2004 | WO2004045587A1 Pharmaceutical tablets containing tibolone and a coating |
| 06/03/2004 | WO2004045586A1 Solidified preparation aiming at promoting drug absorption |
| 06/03/2004 | WO2004045585A1 Media milling using nonspherical grinding media |
| 06/03/2004 | WO2004045584A1 Bupropion hydrochloride solid dosage forms |
| 06/03/2004 | WO2004045583A1 Liposome |
| 06/03/2004 | WO2004045582A1 High-efficiency fusogenic vesicles, methods of producing them, and pharmaceutical compositions containing them |
| 06/03/2004 | WO2004045581A1 Veterinary antiparasite suspension injection |
| 06/03/2004 | WO2004045580A2 Methods of providing controlled-release pharmaceutical compositions and controlled-release pharmaceutical compositions |
| 06/03/2004 | WO2004045579A2 Pharmaceutical compositions and dosage forms of thalidomide |
| 06/03/2004 | WO2004045572A1 Compositions for treating infected skin and mucous membrane comprising an anti-microbial agent and an essential oil |
| 06/03/2004 | WO2004045549A2 Medical devices employing novel polymers |
| 06/03/2004 | WO2004045537A2 Edible film for relief of cough or symptoms associated with pharyngitis |
| 06/03/2004 | WO2004045494A2 Biological glue based on thrombin-conjugated nanoparticles |
| 06/03/2004 | WO2004045305A2 Edible film products and methods of making same |
| 06/03/2004 | WO2004032970A3 Carriers attached to blood cells |
| 06/03/2004 | WO2004030649A3 Methods for producing and stabilising microsuspensions and nanosuspensions by means of amphiphiles and polyelectrolytes |
| 06/03/2004 | WO2004029095A3 Cohesive coprecipitates of sulfated polysaccharide and fibrillar protein and use thereof |
| 06/03/2004 | WO2004025416A3 Bioinformatic method for identifying surface-anchored proteins from gram-positive bacteria and proteins obtained thereby |
| 06/03/2004 | WO2004024213A3 Aerosolized capreomycin for inhibition of pulmonary tuberculosis |
| 06/03/2004 | WO2004024127A3 Solid formulations comprising an indolinone compound |
| 06/03/2004 | WO2004022031A3 Stable probiotic microsphere compositions and their methods of preparation |
| 06/03/2004 | WO2004014337A3 A process for the preparation of dispersible tablet of cephalexin |
| 06/03/2004 | WO2003088761A3 Physiologically compatible, phospholipid-containing, stable and hard matrix |
| 06/03/2004 | WO2003084937A3 Pyrimidinedione derivatives useful for the treatment of inflammation and immunological diseases |
| 06/03/2004 | WO2002078608A8 A simplified and improved method for preparing an antibody or an antibody fragment targeted immunoliposome or polyplex for systemic administration of a therapeutic or diagnostic agent |
| 06/03/2004 | US20040106914 Micro-reservoir osmotic release systems and microtube array device |
| 06/03/2004 | US20040106841 System for administering a combination of therapies to a body lumen |
| 06/03/2004 | US20040106825 e.g., disodium N-(5-chlorosalicyloyl)-8-amN-(10-[2-hydroxybenzoyl]amino)decanoate and disodium N-(10-[2-hydroxybenzoyl]amino)decanoate |
| 06/03/2004 | US20040106763 Linear block polymer |
| 06/03/2004 | US20040106730 Polymer complexes of glucuronoglucanes |
| 06/03/2004 | US20040106674 to provide improved formulations of a full complement of Vitamin E isomers including tocotrienols, which produce a significantly synergistic antioxidant capacity of the formulations that is greater than in heretofore known formulations or delivery |
| 06/03/2004 | US20040106660 Novel pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative |
| 06/03/2004 | US20040106644 Composition for treatment of night sight problems(halos, comas and glare) after refractive surgery, intra ocular lens implant after lensectomy or intraocular implant in phakic patients comprising aceclidine employed at low concentrations |
| 06/03/2004 | US20040106617 Chemical stability of levosimendan solutions can be significantly improved if the pH of the solution is lowered from neutral to lower than 5, preferably to 4.5 or lower, most preferably to 3-4.2 |
| 06/03/2004 | US20040106613 For treating sickle cell disease and glaucoma. |
| 06/03/2004 | US20040106590 Methods and reagents for treating infections of clostridium difficile and diseases associated therewith |
| 06/03/2004 | US20040106576 Derivatives of venlafaxine and methods of preparing and using the same |
| 06/03/2004 | US20040106573 Stable granulates containing s-adenosylmethionine and process for the preparation thereof |
| 06/03/2004 | US20040106568 Nucleic acid sequences containing unmethylated CpG dinucleotides that modulate an immune response including stimulating a Th1 pattern of immune activation, cytokine production, NK lytic activity, and B cell proliferation |
| 06/03/2004 | US20040106561 comprises phytoestrogen isolated from red clover or soya, selected from genistein, daidzein, biochanin A, and/or formononetin; for treatment/prevention of cancer |
| 06/03/2004 | US20040106546 comprises cyclosporin, hyaluronic acid, and polysorbate compound |
| 06/03/2004 | US20040106542 Compositions and methods for enhancing receptor-mediated cellular internalization |
| 06/03/2004 | US20040106539 Agents for the treatment of viral infections |
| 06/03/2004 | US20040106185 Oral bacteriotherapy compositions and methods |
| 06/03/2004 | US20040105980 exhibiting one or more properties, such as magnetic, thermal, optical, electrical, biological, chemical, lubrication, and rheological; core particles of specified average particle size with a plurality of coatings |
| 06/03/2004 | US20040105905 Method for the topical treatment and prevention of inflammatory disorders and related conditions using extracts of feverfew (Tanacetum parthenium) |